{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:14:07Z","timestamp":1794014047696,"version":"4.8.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,10]]},"DOI":"10.1212\/wnl.51.4.1110","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T09:36:31Z","timestamp":1336901791000},"page":"1110-1115","source":"Crossref","is-referenced-by-count":681,"title":["The spectrum of antecedent infections in Guillain-Barre\u0301 syndrome"],"prefix":"10.1212","volume":"51","author":[{"given":"B. C.","family":"Jacobs","sequence":"first","affiliation":[{"name":"From the Departments of Neurology (Drs. Jacobs, van der Meche\u0301, and van Doorn, and M.A. de Klerk), Immunology (Dr. Jacobs), and Virology (Dr. Rothbarth), Erasmus University, Rotterdam; the Department of Trial and Statistics (Dr. Schmitz), Dr. Daniel den Hoed Cancer Center, Rotterdam; and the Department of Immunology and Infectious Diseases (Dr. Herbrink), Diagnostic Centre SSDZ, Delft, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. H.","family":"Rothbarth","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. Jacobs, van der Meche\u0301, and van Doorn, and M.A. de Klerk), Immunology (Dr. Jacobs), and Virology (Dr. Rothbarth), Erasmus University, Rotterdam; the Department of Trial and Statistics (Dr. Schmitz), Dr. Daniel den Hoed Cancer Center, Rotterdam; and the Department of Immunology and Infectious Diseases (Dr. Herbrink), Diagnostic Centre SSDZ, Delft, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.G.A.","family":"van der Meche\u0301","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. Jacobs, van der Meche\u0301, and van Doorn, and M.A. de Klerk), Immunology (Dr. Jacobs), and Virology (Dr. Rothbarth), Erasmus University, Rotterdam; the Department of Trial and Statistics (Dr. Schmitz), Dr. Daniel den Hoed Cancer Center, Rotterdam; and the Department of Immunology and Infectious Diseases (Dr. Herbrink), Diagnostic Centre SSDZ, Delft, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Herbrink","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. Jacobs, van der Meche\u0301, and van Doorn, and M.A. de Klerk), Immunology (Dr. Jacobs), and Virology (Dr. Rothbarth), Erasmus University, Rotterdam; the Department of Trial and Statistics (Dr. Schmitz), Dr. Daniel den Hoed Cancer Center, Rotterdam; and the Department of Immunology and Infectious Diseases (Dr. Herbrink), Diagnostic Centre SSDZ, Delft, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. I.M.","family":"Schmitz","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. Jacobs, van der Meche\u0301, and van Doorn, and M.A. de Klerk), Immunology (Dr. Jacobs), and Virology (Dr. Rothbarth), Erasmus University, Rotterdam; the Department of Trial and Statistics (Dr. Schmitz), Dr. Daniel den Hoed Cancer Center, Rotterdam; and the Department of Immunology and Infectious Diseases (Dr. Herbrink), Diagnostic Centre SSDZ, Delft, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"de Klerk","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. Jacobs, van der Meche\u0301, and van Doorn, and M.A. de Klerk), Immunology (Dr. Jacobs), and Virology (Dr. Rothbarth), Erasmus University, Rotterdam; the Department of Trial and Statistics (Dr. Schmitz), Dr. Daniel den Hoed Cancer Center, Rotterdam; and the Department of Immunology and Infectious Diseases (Dr. Herbrink), Diagnostic Centre SSDZ, Delft, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"van Doorn","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. Jacobs, van der Meche\u0301, and van Doorn, and M.A. de Klerk), Immunology (Dr. Jacobs), and Virology (Dr. Rothbarth), Erasmus University, Rotterdam; the Department of Trial and Statistics (Dr. Schmitz), Dr. Daniel den Hoed Cancer Center, Rotterdam; and the Department of Immunology and Infectious Diseases (Dr. Herbrink), Diagnostic Centre SSDZ, Delft, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1966.00290130003001"},{"key":"e_1_3_1_3_2","first-page":"6","volume":"51","year":"1988","unstructured":"Winer JB, Hughes RAC, Anderson MJ, Jones DM, Kangro H, Watkins RPF. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 1988;51:613-618.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_4_2","first-page":"9","volume":"118","year":"1993","unstructured":"Mishu B, Ilyas AA, Koski CL, et al. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barr\u00e9 syndrome. Ann Intern Med 1993;118:947-953.","journal-title":"Ann Intern Med"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507063330101"},{"key":"e_1_3_1_6_2","first-page":"8","volume":"38","year":"1995","unstructured":"Rees JH, Gregson NA, Hughes RAC. Anti-ganglioside GM1 antibodies in Guillain-Barr\u00e9 syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-816.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410400102"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(96)00051-3"},{"key":"e_1_3_1_9_2","first-page":"6","volume":"62","year":"1997","unstructured":"Jacobs BC, van Doorn PA, Groeneveld JHM, Tio-Gillen AP, van der Mech\u00e9 FGA. Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barr\u00e9 syndrome. J Neurol Neurosurg Psychiatry 1997;62:641-643.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.1_Suppl_1.6S"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410070102"},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","unstructured":"Dowling PC Cook SD. Role of infection in Guillain-Barr\u00e9 syndrome: laboratory confirmation of herpesviruses in 41 cases. Ann Neurol 1981;9(suppl):44-55.","DOI":"10.1002\/ana.410090709"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201023260101"},{"key":"e_1_3_1_14_2","first-page":"7","volume":"35","year":"1994","unstructured":"The Dutch Guillain-Barr\u00e9 Study Group. Treatment of Guillain-Barr\u00e9 syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. Ann Neurol 1994;35:749-752.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","unstructured":"Asbury AK Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome. Ann Neurol 1990;27(suppl):21-24.","DOI":"10.1002\/ana.410270707"},{"key":"e_1_3_1_16_2","unstructured":"Fleiss JL. Statistical methods for rates and proportions ch. 8. New York: John Wiley 1981."},{"key":"e_1_3_1_17_2","unstructured":"Breslow NE Day NE. Statistical methods in cancer research vol. 1. The analysis of case-control studies. Lyon France: IARC 1980."},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1992.tb08868.x"},{"key":"e_1_3_1_19_2","first-page":"5","volume":"104","year":"1991","unstructured":"Boucquey D, Sindic CJM, Lamy M, Delm\u00e9e M, Tomasi JP, Laterre EC. Clinical and serological studies in a series of 45 patients with Guillain-Barr\u00e9 syndrome. J Neurol Sci 1991;104:56-63.","journal-title":"J Neurol Sci"},{"key":"e_1_3_1_20_2","first-page":"5","volume":"55","year":"1994","unstructured":"Ogawa-Goto K, Kubota K, Kurotani A, Abe T. Antibodies against sulfated glycosphingolipids of peripheral nerve myelins detected in patients with human cytomegalovirus infection. J Neuroimmunol 1994;55:55-60.","journal-title":"J Neuroimmunol"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.56.1.1"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880181303"},{"key":"e_1_3_1_23_2","first-page":"2","year":"1986","unstructured":"Westall FC, Root-Bernstein R. Cause and prevention of postinfectious and postvaccinal neuropathies in light of a new theory of autoimmunity. Lancet 1986;i:251-252.","journal-title":"Lancet"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(94)90207-0"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118375"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.1.1"},{"key":"e_1_3_1_27_2","first-page":"2","volume":"8","year":"1994","unstructured":"Suzuki S, Kawaguchi M, Mizuno K, Takama K, Yuki N. Immunological properties and ganglioside recognition by Campylobacter jejuni-enterotoxin and cholera toxin. FEMS Immunol Med Microbiol 1994;8:207-212.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"e_1_3_1_28_2","first-page":"5","volume":"307","year":"1984","unstructured":"Loomes LM, Uemura K, Childs RA, et al. Erythrocyte receptors for Mycoplasma pneumoniae are sialylated oligosaccharides of Ii antigen type. Nature 1984;307:560-563.","journal-title":"Nature"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.51.4.1110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:35:43Z","timestamp":1711535743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.51.4.1110"}},"subtitle":["A case-control study"],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["10.1212\/WNL.51.4.1110"],"URL":"https:\/\/doi.org\/10.1212\/wnl.51.4.1110","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}